The expression levels of TNFRSF18, TNFRSF14, and CD40LG showed significant differences based on clinical characteristics such as tumor stages, tumor grades, and new events Figure 8A–8C (p < 0.05). The gene discussed is TNFRSF18; the disease is neoplasm.